ASLAN Pharmaceuticals Announces $5 Million Registered Direct OfferingSAN MATEO, Calif. and SINGAPORE, March 12, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals Ltd. (Nasdaq: ASLN), a clinical-stage, immunology focused biopharmaceutical company developing innovative...
Globe Newswire•5 months ago